{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Glegg S"],"funding":["CIHR"],"pagination":["103742"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9170132"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["106"],"pubmed_abstract":["<h4>Objectives</h4>In the context of the ongoing overdose crisis, a stark increase in toxic drug deaths from the unregulated street supply accompanied the onset of the COVID-19 pandemic. Injectable opioid agonist treatment (iOAT - hydromorphone or medical-grade heroin), tablet-based iOAT (TiOAT), and safer supply prescribing are emerging interventions used to address this crisis in Canada. Given rapid clinical guidance and policy change to enable their local adoption, our objectives were to describe the state of these interventions before the pandemic, and to document and explain changes in implementation during the early pandemic response (March-May 2020).<h4>Methods</h4>Surveys and interviews with healthcare providers comprised this mixed methods national environmental scan of iOAT, TiOA"],"journal":["The International journal on drug policy"],"pubmed_title":["\"COVID just kind of opened a can of whoop-ass\": The rapid growth of safer supply prescribing during the pandemic documented through an environmental scan of addiction and harm reduction services in Canada."],"pmcid":["PMC9170132"],"funding_grant_id":["FRN 171259","FRN 415293"],"pubmed_authors":["Le Foll B","Kolla G","Brothers TD","Brar R","Fairbairn N","Turnbull J","Sutherland C","Bernstein S","Touesnard N","Glegg S","McCrae K","Rai N","Sereda A","Goyer ME"],"additional_accession":[]},"is_claimable":false,"name":"\"COVID just kind of opened a can of whoop-ass\": The rapid growth of safer supply prescribing during the pandemic documented through an environmental scan of addiction and harm reduction services in Canada.","description":"<h4>Objectives</h4>In the context of the ongoing overdose crisis, a stark increase in toxic drug deaths from the unregulated street supply accompanied the onset of the COVID-19 pandemic. Injectable opioid agonist treatment (iOAT - hydromorphone or medical-grade heroin), tablet-based iOAT (TiOAT), and safer supply prescribing are emerging interventions used to address this crisis in Canada. Given rapid clinical guidance and policy change to enable their local adoption, our objectives were to describe the state of these interventions before the pandemic, and to document and explain changes in implementation during the early pandemic response (March-May 2020).<h4>Methods</h4>Surveys and interviews with healthcare providers comprised this mixed methods national environmental scan of iOAT, TiOA","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Aug","modification":"2025-04-05T16:14:18.345Z","creation":"2024-11-21T00:06:30.12Z"},"accession":"S-EPMC9170132","cross_references":{"pubmed":["35679695"],"doi":["10.1016/j.drugpo.2022.103742"]}}